Do you want to read an article? Please log in or register.
Meta-analysis of pre-operative magnetic resonance imaging (MRI) and surgical treatment for breast cancer
Breast Cancer
Related content
Breast Cancer
The role of magnetic resonance imaging in detection of pathological complete remission in breast cancer patients treated with neoadjuvant chemotherapy: a meta-analysis
Clin. Breast Cancer
Yan-Lin Gu, Si-Meng Pan, Jie Ren, Zhi-Xue Yang, Guo-Qin Jiang
doi: 10.1016/
Breast Cancer
Recent Developments in Metastatic Breast Cancer
healthbook TIMES Oncology Hematology
RECOMMENDED
Breast Cancer
Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk
★ 1
Recommended by
Prof. Dr Beat Thürlimann, Faculty Member
JAMA Oncol.
Geuzinge HA, Obdeijn IM, Rutgers EJT, Saadatmand S, Mann RM, Oosterwijk JC, Tollenaar RAEM, de Roy van Zuidewijn DBW, Lobbes MBI, van 't Riet M, Hooning MJ, Ausems MGEM, Loo CE, Wesseling J, Luiten EJT, Zonderland HM, Verhoef C, Heijnsdijk EAM, Tilanus-Linthorst MMA, de Koning HJ, Familial MRI Screening (FaMRIsc) Study group
doi: 10.1001/jamaoncol.2020.2922.
Breast Cancer
Breast Cancer Screening With Mammography Plus Ultrasonography or Magnetic Resonance Imaging in Women 50 Years or Younger at Diagnosis and Treated With Breast Conservation Therapy
JAMA Oncol.
Cho N, Han W, Han BK, Bae MS, Ko ES, Nam SJ, Chae EY, Lee JW, Kim SH, Kang BJ, Song BJ, Kim EK, Moon HJ, Kim SI, Kim SM, Kang E, Choi Y, Kim HH, Moon WK
doi: 10.1001/
Breast Cancer
Overall survival of CDK4/6-inhibitors-based treatments in clinically relevant subgroups of metastatic breast cancer: systematic review and meta-analysis
J Natl Cancer Inst.
Schettini F, Giudici F, Giuliano M, Cristofanilli M, Arpino G, Del Mastro L, Puglisi F, De Placido S, Paris I, De Placido P, Venturini S, De Laurentis M, Conte P, Juric D, Llombart-Cussac A, Pusztai L, Prat A, Jerusalem G, Di Leo A, Generali D
doi: 10.1093/jnci/djaa071.
RECOMMENDED
Breast Cancer
Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk
J Clin Oncol.
Arasu VA, Miglioretti DL, Sprague BL, Alsheik NH, Buist DSM, Henderson LM, Herschorn SD, Lee JM, Onega T, Rauscher GH, Wernli KJ, Lehman CD, Kerlikowske K
doi: 10.1200/JCO.18.00378.
Gynecologic Cancer
Efficacy of cancer vaccines in selected gynaecological breast and ovarian cancers: A 20-year systematic review and meta-analysis
Eur J Cancer.
Dafni U, Martín-Lluesma S, Balint K, Tsourti Z, Vervita K, Chenal J, Coukos G, Zaman K, Sarivalasis A, Kandalaft LE
doi: 10.1016/j.ejca.2020.10.014.
Breast Cancer
Prognostic value of endocrine treatment-related symptoms in patients with breast cancer: a meta-analysis
Breast Cancer Res Treat.
Zheng Q, Xia W, Lu Q, Hong R, Qin G, Xu F, Qin T, Shi Y, Yuan Z, Wang S
doi: 10.1007/s10549-016-3995-5.
Breast Cancer
Optimal duration of adjuvant trastuzumab in treatment of early breast cancer: a meta-analysis of randomized controlled trials
Breast Cancer Res Treat.
Niraula S, Gyawali B
doi: 10.1007/s10549-018-4967-8.